💊SGLT2i pleiotropic effects have demonstrated efficacy across various cardiovascular conditions, ranging from acute to chronic coronary syndromes and extending to arrhythmias, valvular heart disease, cardiomyopathies, cardio-oncology, and cerebrovascular disease!
🔍Our review provides an overview of the current literature on the potential mechanisms underlying the effectiveness of SGLT2i across a wide range of cardiovascular diseases, beyond HF.
@ELS_Cardiology @ElsevierConnect@matt_armi@CarminePizzi@L_Bergamaschi
#Pharmacology #ClinicalPharmacology #DrugDevelopment #SGLT2i
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 ... https://t.co/5ahjNjywSA
Hats off for the brilliant International Adrenal Cancer Symposium at @MDAndersonNews! Outstanding level of expertise and innovation. @A5_Adrenal@ENSAT_news It was an honor to share our work on circulating cell free DNA from @Bham_AT which was selected for the Abstract Award.
Congrats @DocTux92 and Kimberly for winning the poster prize on salivary cortisol profile in adrenal incidentalomas at wonderful @ENSAT_news meeting in Palma!
It’s a wrap!! It has been a wonderful event with huge participation, great science and plenty of network opportunities! Well done to local organisers Rodrigo Toledo and team @RToledoLab 👏 and the #ENS@T ExCo.
See you all next year in #Belgrade!
Did you remember to sign up for the 9th International Adrenal Cancer meeting?
Nov 22-23, 2024 in Houston, Tx USA.
Agenda and info with QR code below.
#adrenalcancer
Thanks @ENSAT_news for the opportunity, to all the contributors around Europe that made this possible and to the mastermind behind the project @gdd1982. See you all in Palma!
🚨 SAVE THE DATE! Not to be missed the International Adrenal Cancer Symposium taking place in Houston (Texas) - see the link for details, abstract deadlines, travel grants and registration https://t.co/mYFw54tJo9 #adrenalcancer#adrenalresearch#cureACC@LetsCureAcc
A warm welcome to @DocTux92, who is MD, Specialist in Endocrinology and current PhD student in Endocrine Molecular Pathology at Bologna University/Sant'Orsola Policlinic (Italy). He has joined our adrenal team under the supervision of Dr @CryRonchi for a visit of 18 months.
Just published on @Eur_Thyroid_J! Great effort among Italian teams to study clinical relationship between COVID 19 and subacute thyroiditis, it was an honour for me! #covid#thyroid#endocrinology
https://t.co/pNlDFO4K4t
New research: Monitoring adrenal insufficiency through salivary steroids: a pilot study by Lorenzo Tucci et al
From EJE Vol. 190, Issue 4, April 2024
Read the Open Access article here👉https://t.co/kp2zH3yjeA